ImmunoGen Inc., a Waltham biotechnology company, announced Monday the appointment of Charles Morris as executive vice president and chief development officer. In that capacity, Morris is responsible for leading all aspects of product development. He reports to Daniel Junius, ImmunoGen’s president and chief executive.
Unlimited access to BostonGlobe.com for only 99 cents for the first 4 weeks.Sign up
Are you a home delivery subscriber?
Get FREE access as part of your print subscriptionStart Here
Contact us for help